GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
57 hedge funds and large institutions have $65.7M invested in Genocea Biosciences, Inc. in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $136M → $65.7M (-$69.9M)
Holders
57
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$598K | |
| 3 | +$569K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$334K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$236K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$2.05M | |
| 3 | -$1.1M | |
| 4 |
JP Morgan Chase
New York
|
-$983K |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$827K |